Quality of twelve clarithromycin dry syrup formulations-bitterness, grittiness and uniformity of drug loading.
The objective of the study was to evaluate the bitterness, grittiness and uniformity of drug loading as measures of the quality of 12 formulations of clarithromycin dry syrup (CAMDS), comprising one branded and 11 generic products. Some of the generic CAMDS formulations were more bitter than the branded product while others had similar bitterness when tested as aqueous suspensions. Only one generic product was less bitter than the branded product when tested as a suspension in acidic sports drink. The usual dissolution test described in JP XV could not be used to evaluate the bitterness of the products. A brief dissolution test using only 12.5 ml of water was used to evaluate the bitterness of the products in aqueous suspensions. There were considerable variances in the grittiness of the various products, which were independent of particle size. Changes in grittiness level seemed to be correlated with changes in the intensity of bitterness due to the disintegration of the formulation. Finally, there was less variation in the uniformity of drug loading for the branded product than for the generic products. These data may be useful when selecting which CAMDS formulation to prescribe.
Ishizaka
Toshihiko
T
School of Pharmaceutical Sciences, Mukogawa Women's University, Hyogo, Japan.
Okada
Sachie
S
Tokuyama
Emi
E
Mukai
Junji
J
Uchida
Takahiro
T
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry*; D001628:Beverages; D002626:Chemistry, Pharmaceutical; D017291:Clarithromycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010316:Particle Size; D015532:Rehydration Solutions; D012995:Solubility; D013535:Suspensions; D013649:Taste
D000900:Anti-Bacterial Agents; D015532:Rehydration Solutions; D013535:Suspensions; D017291:Clarithromycin